Illumina Inc
Market cap $37.0B
$239.55
ILMN
$239.55
-2.30% today
Buy with €1M virtual cash · No real money
Illumina Inc (ILMN) is a publicly traded company listed on the XNAS. As of September 18, 2026, Invest's signal rates ILMN a Buy, with the stock up 137% over the past year. You can practice trading ILMN risk-free with €1,000,000 in virtual cash.
Key stats
As of September 18, 2026
Market Cap
$37.0B
Volume
1.1M
52-wk High
$250.06
52-wk Low
$88.00
Day High
$250.06
Day Low
$239.45
P/E (TTM)
44.69
Revenue (TTM)
$4.5B
EPS (TTM)
$5.36
Performance
1M
+16.9%
6M
+89.2%
1Y
+137.5%
Invest signal · ILMN
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
ILMN overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev +6.2%Revenue
$1BEPS (diluted)
$1.35 per shareLatest ILMN news
Environmental DNA Market to Reach USD 3.04 Billion by 2031, Growing at a CAGR of 14.9% — MarketsandMarkets™
GlobeNewswire Inc. · Sep 10
Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now
Zacks Investment Research · Sep 9
Epigenetics Market Intelligence Report 2026: Strong Demand from Oncology, Precision Medicine, Pharmaceutical Research, and Liquid-Biopsy Development
GlobeNewswire Inc. · Sep 9
The Zacks Analyst Blog Highlights FANUY, ABBNY, KYCCF, NVDA, ISRG, ILMN, NOVT, BOTZ, ROBO, ROBT and IBOT
Zacks Investment Research · Sep 8
Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?
Zacks Investment Research · Sep 8
About Illumina Inc
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms.
Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Employees
8,650
30-Day Win Rate · ILMN
14 days
10 days
Last 24 sessions
How to practice trading ILMN
- 1
Use the ILMN buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top ILMN traders on Invest
Full leaderboardFrequently asked questions
Is ILMN a good stock to buy right now?
As of September 18, 2026, Invest's signal rates ILMN a Buy, based on its price trend, valuation, and fundamentals (P/E around 44.7), with the stock up 137% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading ILMN risk-free first.
What is Illumina Inc's (ILMN) market cap?
Illumina Inc has a market capitalization of approximately $37.0B, on trailing-twelve-month revenue of about $4.5B.
How has ILMN stock performed?
ILMN is up 137% over the past year and up 89% over six months. Its 52-week range runs roughly from $88.00 to $250.06. Past performance doesn't predict future results.
How can I practice trading ILMN for free?
On Invest you get €1,000,000 in virtual cash and can buy ILMN at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare ILMN with peers